塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/02/15 | 5,472 | 5,531 | 5,437 | 5,494 | +84 | +1.6% | 1,609,400 |
2017/02/14 | 5,607 | 5,621 | 5,408 | 5,410 | -240 | -4.2% | 1,950,900 |
2017/02/13 | 5,680 | 5,680 | 5,598 | 5,650 | +2 | ±0% | 1,048,200 |
2017/02/10 | 5,607 | 5,671 | 5,585 | 5,648 | +100 | +1.8% | 1,480,900 |
2017/02/09 | 5,562 | 5,594 | 5,543 | 5,548 | -66 | -1.2% | 670,300 |
2017/02/08 | 5,592 | 5,618 | 5,560 | 5,614 | +9 | +0.2% | 584,200 |
2017/02/07 | 5,634 | 5,649 | 5,592 | 5,605 | -39 | -0.7% | 828,000 |
2017/02/06 | 5,680 | 5,680 | 5,613 | 5,644 | +10 | +0.2% | 929,900 |
2017/02/03 | 5,552 | 5,655 | 5,494 | 5,634 | +182 | +3.3% | 1,475,100 |
2017/02/02 | 5,400 | 5,490 | 5,397 | 5,452 | +9 | +0.2% | 1,522,300 |
2017/02/01 | 5,418 | 5,469 | 5,337 | 5,443 | +18 | +0.3% | 966,100 |
2017/01/31 | 5,450 | 5,492 | 5,417 | 5,425 | -103 | -1.9% | 1,013,600 |
2017/01/30 | 5,540 | 5,549 | 5,488 | 5,528 | -4 | -0.1% | 553,500 |
2017/01/27 | 5,590 | 5,614 | 5,502 | 5,532 | +1 | ±0% | 906,200 |
2017/01/26 | 5,452 | 5,542 | 5,446 | 5,531 | +118 | +2.2% | 1,013,100 |
2017/01/25 | 5,440 | 5,465 | 5,359 | 5,413 | -20 | -0.4% | 1,087,000 |
2017/01/24 | 5,509 | 5,550 | 5,430 | 5,433 | -85 | -1.5% | 1,093,700 |
2017/01/23 | 5,470 | 5,564 | 5,450 | 5,518 | +47 | +0.9% | 1,649,500 |
2017/01/20 | 5,504 | 5,556 | 5,462 | 5,471 | -56 | -1% | 989,700 |
2017/01/19 | 5,529 | 5,554 | 5,487 | 5,527 | +39 | +0.7% | 959,000 |
2017/01/18 | 5,470 | 5,517 | 5,450 | 5,488 | +17 | +0.3% | 976,600 |
2017/01/17 | 5,574 | 5,574 | 5,471 | 5,471 | -92 | -1.7% | 992,000 |
2017/01/16 | 5,580 | 5,615 | 5,548 | 5,563 | -21 | -0.4% | 849,100 |
2017/01/13 | 5,500 | 5,599 | 5,500 | 5,584 | +80 | +1.5% | 1,460,500 |
2017/01/12 | 5,590 | 5,590 | 5,480 | 5,504 | -212 | -3.7% | 1,571,400 |
2017/01/11 | 5,740 | 5,740 | 5,669 | 5,716 | ±0 | ±0% | 846,200 |
2017/01/10 | 5,720 | 5,771 | 5,690 | 5,716 | +31 | +0.5% | 1,580,200 |
2017/01/06 | 5,699 | 5,716 | 5,652 | 5,685 | +6 | +0.1% | 1,315,700 |
2017/01/05 | 5,648 | 5,731 | 5,621 | 5,679 | +93 | +1.7% | 1,302,100 |
2017/01/04 | 5,622 | 5,670 | 5,571 | 5,586 | -13 | -0.2% | 1,147,100 |
2016/12/30 | 5,510 | 5,620 | 5,510 | 5,599 | +108 | +2% | 915,600 |
2016/12/29 | 5,565 | 5,578 | 5,473 | 5,491 | -35 | -0.6% | 716,900 |
2016/12/28 | 5,497 | 5,567 | 5,467 | 5,526 | -17 | -0.3% | 657,200 |
2016/12/27 | 5,551 | 5,635 | 5,536 | 5,543 | -8 | -0.1% | 792,800 |
2016/12/26 | 5,500 | 5,578 | 5,489 | 5,551 | +94 | +1.7% | 912,200 |
2016/12/22 | 5,380 | 5,480 | 5,371 | 5,457 | +34 | +0.6% | 1,197,000 |
2016/12/21 | 5,416 | 5,544 | 5,410 | 5,423 | +25 | +0.5% | 2,177,700 |
2016/12/20 | 5,240 | 5,416 | 5,223 | 5,398 | +155 | +3% | 1,635,500 |
2016/12/19 | 5,224 | 5,260 | 5,202 | 5,243 | +19 | +0.4% | 745,100 |
2016/12/16 | 5,240 | 5,245 | 5,192 | 5,224 | +27 | +0.5% | 1,195,200 |
2016/12/15 | 5,159 | 5,217 | 5,147 | 5,197 | +48 | +0.9% | 1,175,500 |
2016/12/14 | 5,155 | 5,197 | 5,136 | 5,149 | -25 | -0.5% | 909,900 |
2016/12/13 | 5,004 | 5,180 | 5,004 | 5,174 | +170 | +3.4% | 1,626,700 |
2016/12/12 | 4,991 | 5,007 | 4,921 | 5,004 | +83 | +1.7% | 1,785,100 |
2016/12/09 | 4,854 | 4,956 | 4,818 | 4,921 | +8 | +0.2% | 3,456,800 |
2016/12/08 | 5,100 | 5,101 | 4,847 | 4,913 | -263 | -5.1% | 3,607,100 |
2016/12/07 | 5,300 | 5,307 | 5,170 | 5,176 | -143 | -2.7% | 1,977,300 |
2016/12/06 | 5,460 | 5,460 | 5,162 | 5,319 | -49 | -0.9% | 1,359,900 |
2016/12/05 | 5,404 | 5,467 | 5,356 | 5,368 | +48 | +0.9% | 1,275,700 |
2016/12/02 | 5,340 | 5,371 | 5,287 | 5,320 | -57 | -1.1% | 1,224,700 |
1901~
1950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム